Alpha-Rich Ideas
First BanCorp: Blood In The Streets - Time To Buy
by Ashleigh Rogers
Editor's notes: Macro events and other headwinds have created an excellent opportunity in First BanCorp. Insurance and Financials expert Ashleigh Rogers cites catalysts for potential upside of 75% with minimal downside risk.
Stocks Moving From Alpha-Rich Ideas
Senvest Capital's (SVCTF, SEC.TO) Toronto-listed shares are +11% from Oct. 22, when buysider Weighing Machine highlighted a steep discount to NAV and a significant near-term catalyst. Read article »
Inter Parfums (IPAR) is +21% since August, when Bishop Research and Analytics identified that confusion over the Burberry transaction's impact on EPS had left IPAR shares undervalued. Read article »
Breaking Alpha-Rich Ideas (for Pro Subscribers) Learn more »
A Low-Risk Double by Christopher Owens
First BanCorp: Blood In The Streets - Time To Buy by Ashleigh Rogers
The Biodiesel Tide Is Going Out: Neste Oil Is Swimming Naked, 75% Downside by Asset Plays Investing
Societe D'Edition Canal Plus: A Low-Risk Bet On Further Vivendi Restructuring by Mike Arnold
Long Ideas
Merrimack - Not Bad News? by Ross Breckenridge
Sirius XM: Do The Analysts Have It Correct? by Crunching Numbers
Solid Investing Opportunity With National Oilwell Varco by Fusion Research
Rediff.com's E-Commerce Transition May Provide Significant Upside To The Stock by GS Analytics
Why Broadcom Can Go On A Bull Run From Its Beaten-Down Levels by Vinay Kumar Singh
Advanced Micro Devices Is Undervalued: Great Bet For Long-Term Investment by E-Investing Analysis
Balchem: A Great Way To Invest In Natural Gas And Global Food Production by Michael DiBattista
Ariad Is Rising With Catalysts Approaching by Stock Whisper
Surprise, Microsoft's RT Is Actually A Great Product by Adrian McCarroll
BlackBerry: Spinning BBM Into Facebook by Infinity Group
Micron's Inventory Myth by Electric Phred
Opko Health: Rayaldy's Major Unforeseen Impact by Josh Ginsburg
ViaSat: Defying The Naysayers And Changing Everything by Mark Fidelman
Upcoming Earnings May Catalyze This Underfollowed Spin-Off by No Mean Sum
A New Leading Sector In The Market: Oil And Gas Exploration by Bill Gunderson
Protalix: Undervalued Growth, Plus A Possible Biotech Breakthrough by SeekingValue
Orbital Sciences Offers 50% To 100% Upside With An Out Of This World Future by Richard Berger
NQ Mobile: Clearing Up The Muddied Waters Means A Short Squeeze On The Horizon by Velocity Trading
CSX Corp.: Should Bulls Be Worried About Weakening Coal Revenue? by Fusion Research
Why Netflix Is A Solid Buy by Fusion Research
Growth Ride Just Got Started For Schlumberger by Fusion Research
Neurocrine Will Get Second Chance To Offer Up VMAT-2 Data In December by Jason Napodano
NQ Mobile: Behind Smoke And Mirrors Lies The Truth, Part 2 by Toro Investment Partners
What I Find Strange About The Short Argument On J.C. Penney by Dante's Investing Ideas
Orbotech: Relishing In China's Growing Appetite For Consumer Electronics by Nassarius Capital
Five Prime: A Growing Oncology And Inflammatory Player With A Promising Pipeline by Biomed Group
Endocyte's Plunge Ignores Drug's $2.5B Potential by YCharts
MSC Industrial Comes Through In A Tough Quarter by Stephen Simpson, CFA
VASCO Is An Overlooked Internet Security Firm With 50% Upside by Marshall Hargrave
Buy Novavax On Vaccine Market Growth by Stock Whisper
Passage Of Compounding Safety Bill Positions TherapeuticsMD In Hormone Therapy Market by Cockrell Group
Market Irrationality Or Pricing Perfection: Apple, Google And Amazon by Tom Shaughnessy
Portola Pharmaceuticals: A Biotech Company With Plenty Of Room To Grow by Henry Kawabe
Superior Energy Services Looks To Live Up To Its Name by Stephen Simpson, CFA
KKR - Value At The Gate by Yaniv Uliel
Bull Of The Day: EPAM Systems by Zacks Investment Research
This Is How DuPont Will Remain Profitable Long Term by John Mylant
Apple Should Buy Broadcom by Ashraf Eassa
Halliburton's Share Buybacks, Dividend Increases: Sustainable In An Evolving Market? by Ron McWilliams
Herbalife Earnings And Stock Price Bolster CEO Johnson by Don Dion
Perceptron: Small Company, Limitless Potential by Jonathan Faison
Lionsgate: The Odds Are Ever In Your Favor by AstroInvestments
Are You Also Wrong On Microsoft? by Shmulik Karpf
IPG Photonics - Power To The Last Mile by Bruce Pile
I Concede Defeat On ARM Holdings by Ashraf Eassa
Corning: A Real Glass Act With A Ton Of Upside by Douglas E. Johnston
Aspen Group: Soaring Revenues And Declining Losses by JoeNatural
DSW Inc.: A High-Conviction, Fast-Growing Idea by Logic
Take-Two Interactive: What You Need To Know About The Blowout Quarter - GTA V Sales And Earnings Results by Mark Kowalski
Why Apple Will Buy BlackBerry by Rizzi Capital
What To Expect From InvenSense In 2014 by Esekla
Supernus Pharma: An Overlooked, Undervalued Investment Opportunity by Cockrell Group
Afren: Growing Production And Reserves, Yet Severely Undervalued by Fund Gurus
Superior Industries: With No Debt, A Strong Balance Sheet And Increasing Dividends, Investors Should Take Note by ValueArtifex
How ARC Group Worldwide, Inc. Could Be Valued At $50-$70 In The 3D Printing Group by super-trades
Navidea Is On Track To File SNDA For Lymphoseek; CEO Expects A Positive Outcome by Ben Yoffe
Baidu's Revenue Zooms, Tries Thailand by Doug Young
Apple Will Get Its Groove Back In FY2014 by Saibus Research
Innotrac - Capitalizing On Strong Growth In E-Fulfillment Outsourcing by The Growth Path Guru
Apple Surprises Skeptics As iPhone Registers Record Sales by Bidness Etc
Celldex: What's All The Excitement About? by Smith On Stocks
NeoStem: Major Developments You Might Have Missed by The Swiss Trader
Loyalist Group: Interesting Consolidation Play For Micro-Cap Investors by Monolith Investments
Short Ideas
InterActive Is Slowing Down by Seeking Profits
The Shaky Data Point Propping Up Lululemon Stock by YCharts
Tangoe - Turning Off The Music To This Dance by The Forensic Factor
Pumping The Brakes On Monro Muffler Brake & Service by Marshall Hargrave
Gulfport Energy Has Hit A Turning Point And The Bleeding Will Continue by Value Digger
ModernGraham Valuation Of AT&T by Benjamin Clark
Time To Sell LinkedIn by Dana Blankenhorn
Money Back Guarantee Makes Herbalife Even More Sinister by Matt Stewart
Sarepta Therapeutics: Underappreciated Clinical And Regulatory Risk Following Analysis Of Prosensa Failure by Steven Breazzano
Not The Investment Of A 'Life Time' by Marshall Hargrave
Did The FDA Just Issue Amarin's Death Blow Again? by Quoth the Raven
ARMOUR Residential: Dismal Q3 Results Confirm Short Thesis, Dividend Cuts Likely by Achilles Research
RadioShack: Is New Financing Permitted Under Its Indenture? by The Stock Stooge
Commvault: Red Flags Galore by Akram's Razor
Even With A Change In Business Model, Angie's List Is Overvalued by Weighing Machine
Dimon's Deal At Risk Of Collapse And Cohen's SAC To Plead To Fraud by Don Dion
The Time To Short ParkerVision Is Now by Alpha Exposure
Quick Picks & Lists
Qunar Boosts IPO Price Range, NQ Hit Again by Doug Young
Winners And Losers Of Big Bank Lawsuits by Tom Dorsey
Comcast Corporation - Competition And High Expectations Limit Short-Term Potential by The Value Investor
Facebook Bigger Than Disney by Bespoke Investment Group
The Same Problem Haunts These 3 Tech Majors by BubbleBustInvesting
General Motors - North America And Europe Drive Improvements by The Value Investor
Google Is Set To Transform The Online Video Streaming Industry by Vivek Gupta
Facebook's Interest In BlackBerry Is Surprising, But Logical by George Kesarios
3 Undervalued Mid-Caps by Weighing Machine
S&P 1500 Most Heavily Shorted Stocks by Bespoke Investment Group
Silver Miners: Straight-Up Or Played In A Basket by Biz Bluetree
CoreValve Data Cause FDA To Waive Panel Requirement by EP Vantage
High Flying Stocks Are Beginning To Crack by George Kesarios
Southern Copper Vs. Freeport: Which Is The Better Buy? by Price Point
Capesize Spot Rates Crash Below Last Year's Rate by The Specialist
IBM Versus Oracle by Investing Sidekick
When Dilution Is A Buy Signal by Charles Russo
Biotechnology: Finding The Best And Worst Value In The Industry by Brian Nichols
Under The Radar Earnings: Minerals Technologies, SCANA Corp. And Trimble Navigation by Stock Traders Daily
Ahead Of Earnings: Acorda Therapeutics, Boyd Gaming, Barrick Gold And Advance Auto Parts by Stock Traders Daily
Cramer's Picks
Cramer's Lightning Round - Don't Freak Out About Marketo (10/30/13) by SA Editor Miriam Metzinger
Cramer's Mad Money - Buffalo Wild Wings' Grand Slam Quarter (10/30/13) by SA Editor Miriam Metzinger
Insider Ownership
Insiders Are Buying Belo Sun Mining by Markus Aarnio
Insiders Are Buying Sprague Resources by Markus Aarnio
Insiders Are Buying Mirati Therapeutics by Markus Aarnio
IPO Analysis
IPO Preview: Essent Group by IPOdesktop
IPO Preview: 58.com by IPOdesktop
IPO Preview: Marcus & Millichap by IPOdesktop
QUNAR IPO Travels To Investors From Baidu by Don Dion
Container Store IPO Has Massive Competitors by Don Dion
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
